Literature DB >> 24675105

Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms.

T L Lasho1, A Pardanani2, A Tefferi2, D I Smith3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24675105     DOI： 10.1038/leu.2014.117

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  p53 lesions in leukemic transformation.

Authors:  Ashot Harutyunyan; Thorsten Klampfl; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal.

Authors:  Zhen Zhao; Johannes Zuber; Ernesto Diaz-Flores; Laura Lintault; Scott C Kogan; Kevin Shannon; Scott W Lowe
Journal:  Genes Dev       Date:  2010-07-01       Impact factor: 11.361

3.  PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.

Authors:  Yuwen Li; Jisoo Park; Longzhen Piao; Gyeyeong Kong; Yongbaek Kim; Kyeong Ah Park; Tiejun Zhang; Janghee Hong; Gang Min Hur; Jeong Ho Seok; Seung-Won Choi; Byong Chul Yoo; Brian A Hemmings; Derek P Brazil; Seon-Hwan Kim; Jongsun Park
Journal:  Cell Signal       Date:  2012-09-11       Impact factor: 4.315

4.  JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms.

Authors:  M Nakatake; B Monte-Mor; N Debili; N Casadevall; V Ribrag; E Solary; W Vainchenker; I Plo
Journal:  Oncogene       Date:  2011-07-25       Impact factor: 9.867

Review 5.  TP53 in hematological cancer: low incidence of mutations with significant clinical relevance.

Authors:  Shoshana Peller; Varda Rotter
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

6.  Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia.

Authors:  Takashi Kumagai; Ayalew Tefferi; Letetia Jones; H Phillip Koeffler
Journal:  Leuk Res       Date:  2005-01-15       Impact factor: 3.156

7.  Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53.

Authors:  Sungman Park; Donghwa Kim; Han C Dan; Huihua Chen; Joseph R Testa; Jin Q Cheng
Journal:  J Biol Chem       Date:  2012-02-14       Impact factor: 5.157

8.  Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing.

Authors:  Terra Lasho; Sarah H Johnson; David I Smith; John D Crispino; Animesh Pardanani; George Vasmatzis; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2013-08-01       Impact factor: 10.047

Review 9.  Clonal evolution in hematological malignancies and therapeutic implications.

Authors:  D A Landau; S L Carter; G Getz; C J Wu
Journal:  Leukemia       Date:  2013-08-27       Impact factor: 11.528

10.  AKT is a therapeutic target in myeloproliferative neoplasms.

Authors:  I Khan; Z Huang; Q Wen; M J Stankiewicz; L Gilles; B Goldenson; R Schultz; L Diebold; S Gurbuxani; C M Finke; T L Lasho; P Koppikar; A Pardanani; B Stein; J K Altman; R L Levine; A Tefferi; J D Crispino
Journal:  Leukemia       Date:  2013-06-10       Impact factor: 11.528
View more
  1 in total

1.  Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line.

Authors:  Tianlong Liu; Tiejun Zhang; Feng Zhou; Jitao Wang; Xiaohu Zhai; Nan Mu; Jongsun Park; Minna Liu; Wenxing Liu; Peijin Shang; Yi Ding; Aidong Wen; Yuwen Li
Journal:  Cancer Cell Int       Date:  2017-10-04       Impact factor: 5.722
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.